Company

Cadence

Clinical AI company that automates treatment of chronic diseases including heart failure, hypertension, and diabetes by combining remote patient monitoring with AI-driven medication management and care coordination

AIHealthcare & Biotech

People

Chris Altchekfounder

Funding History

Jun 29, 2026Series C

Cadence raised a $100M Series C. The company uses AI agents to automate treatment of chronic diseases including heart failure, hypertension, and diabetes, managing nearly 100,000 patients across 21 leading US hospital systems.

100M

Investors

General Catalyst

News

Interviews (1)

Cadence raises $100M Series C after showing AI can prevent 20 strokes a week and save Medicare $2.7M per week

29 Jun 2026